SCHEMBL20154914

SCHEMBL20154914

Nc1ncc(Br)c(NCCN2CCOCC2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 2/20 0.45
TLR7 Q9NYK1 2/20 0.45
TOP2A P11388 1/20 0.44
PIM1 P11309 1/20 0.44
CYP1A2 P05177 6/20 0.44
CYP3A4 P08684 6/20 0.44
LMNA P02545 5/20 0.44
CYP2D6 P10635 5/20 0.44
HIF1A Q16665 4/20 0.44
HSD17B10 Q99714 4/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
CYP2C19 P33261 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
TSHR P16473 1/20 0.44
TLR9 Q9NR96 2/20 0.43
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
ALOX15 P16050 2/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17790910 0.84 CXCR4 (0.50) TLR8TLR7TOP2ACYP1A2CYP3A4
SCHEMBL3448525 0.84 CXCR4 (0.50) TOP2APIM1CYP1A2CYP3A4LMNA
SCHEMBL3951404 0.80 TOP2A (0.45) TOP2APIM1CYP1A2CYP3A4LMNA
SCHEMBL22673093 0.78 ULK1 (0.43) TLR8TLR7LMNAHSD17B10MEN1
SCHEMBL20155270 0.77 IRAK4 (0.67) CYP1A2CYP3A4LMNACYP2D6HIF1A
SCHEMBL3447060 0.77 MAPK1 (0.47) PIM1LMNAHIF1AHSD17B10KMT2A
SCHEMBL18172301 0.76 PIM1 (0.44) PIM1CYP1A2CYP3A4LMNACYP2D6
SCHEMBL13648535 0.76 TNK2 (0.57) CYP3A4LMNACYP2D6MEN1KMT2A
SCHEMBL22439327 0.75 P2RX3 (0.56) CYP1A2CYP3A4LMNACYP2D6HIF1A
SCHEMBL29839469 0.75 P2RX3 (0.56) CYP1A2CYP3A4LMNACYP2D6HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3530656-B1 2-SUBSTITUTED AROMATIC RING-PYRIMIDINE DERIVATIVE, AND PREPARATION AND APPLICATION THEREOF UNIV ZHEJIANG (CN) 2022-01-05 EP disclosed
US-10822327-B2 2-substituted aromatic ring-pyrimidine derivative and preparation and application thereof ZHEJIANG UNIVERSITY (CN) 2020-11-03 US disclosed
EP-3530656-A1 2-SUBSTITUTED AROMATIC RING-PYRIMIDINE DERIVATIVE, AND PREPARATION AND APPLICATION THEREOF Zhejiang University (CN) 2019-08-28 EP disclosed
WO-2018086547-A1 2-SUBSTITUTED AROMATIC RING-PYRIMIDINE DERIVATIVE, AND PREPARATION AND APPLICATION THEREOF 浙江大学 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10822327-B2 2-substituted aromatic ring-pyrimidine derivative and preparation and application thereof CHEK1, CHEK2, PLK1 TLR8 3840/4885TLR7 1653/4885TOP2A 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.